The research is described in the Jan. 9 issue of the Proceedings of the National Academy of Sciences, or PNAS. This “chimera” molecule, dubbed Syn-RiboTAC, boasts a dual-pronged attack on the disease: one head hunts down a key piece of Parkinson’s-causing …
 |
| READ THE ORIGINAL POST AT greekcitytimes.com |
